Where it is registered
Each register with its number of medicines and a few of them.
Saudi Arabia
SFDA · 1 medicine · Historical list
All medicines with Inactivated b pertussis
Every register, a page at a time. Strengths and packs are on each medicine’s page.
30 results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| PediarixCombination | United States | 0.5ML | Injection | Marketed | GlaxoSmithKline Biologicals |
| PentacelCombination | United States | 0.5ML | Injection | Marketed | Sanofi Vaccines Canada Ltd. |
| VaxelisCombination | United States | 0.5ML | Injection | Marketed | MSP Vaccine Company |
| VaxelisCombination | United States | 0.5ML | Injection | Marketed | MSP Vaccine Company |
| QUINVAXEM Injection*Combination | Saudi Arabia | Authorised | Berna Biotech Korea Corporation | ||
| Infanrix Hexa | European Union | Authorised | GlaxoSmithKline Biologicals S.A. | ||
| Vaxelis | European Union | Authorised | MCM Vaccine B.V. | ||
| Hexacima | European Union | Authorised | Sanofi Winthrop Industrie | ||
| Hexyon | European Union | Authorised | Sanofi Winthrop Industrie | ||
| PentacelCombination | Canada | 15 LF / 0.5 ML + 20 MCG / 0.5 ML + 5 MCG / 0.5 ML + 10 MCG / 0.5 ML + 3 MCG / 0.5 ML + 20 MCG / 0.5 ML + 29 UNIT / 0.5 ML + 7 UNIT / 0.5 ML + 26 UNIT / 0.5 ML + 30 MCG / 0.5 ML + 5 LF / 0.5 ML | Suspension | Marketed | Sanofi Vaccines Canada LTD. |
| Infanrix HexaCombination | Canada | 25 LF / 0.5 ML + 25 MCG / 0.5 ML + 10 MCG / 0.5 ML + 10 MCG / 0.5 ML + 8 MCG / 0.5 ML + 25 MCG / 0.5 ML + 40 UNIT / 0.5 ML + 8 UNIT / 0.5 ML + 32 UNIT / 0.5 ML + 10 LF / 0.5 ML + 40 MCG / 0.5 ML | Suspension | Marketed | Glaxosmithkline INC |
| Boostrix-PolioCombination | Canada | 2.5 LF / 0.5 ML + 8 MCG / 0.5 ML + 40 D / 0.5 ML + 8 D / 0.5 ML + 32 D / 0.5 ML + 2.5 MCG / 0.5 ML + 8 MCG / 0.5 ML + 5.0 LF / 0.5 ML | Suspension | Marketed | Glaxosmithkline INC |
| Infanrix-Ipv/HibCombination | Canada | 30 UNIT / 0.5 ML + 25 MCG / 0.5 ML + 10 MCG / 0.5 ML + 40 UNIT / 0.5 ML + 8 UNIT / 0.5 ML + 32 UNIT / 0.5 ML + 8 MCG / 0.5 ML + 25 MCG / 0.5 ML + 40 UNIT / 0.5 ML | Suspension | Marketed | Glaxosmithkline INC |
| KinrixCombination | United States | 0.5ML | Injection | Marketed | GlaxoSmithKline Biologicals |
| QuadracelCombination | United States | 0.5ML | Injection | Marketed | Sanofi Vaccines Canada Ltd. |
| Boostrix Polio Suspension for InjectionCombination | Singapore | 2.5 Lf/ 0.5 ml - not less than 2 IU + 8 mcg/0.5ml + 40 DU/0.5 ml + 8 DU/0.5 ml + 32 DU/0.5 ml + 2.5 mcg/0.5 ml + 8 mcg/0.5 ml + 5.0 Lf/0.5ml - not less than 20 IU | injection, suspension | Authorised | Glaxosmithkline Pte LTD |
| Hexaxim Suspension for Injection in Pre-Filled SyringeCombination | Singapore | 30 Lf (>= 20 IU)/0.5 mL + 25 μg/0.5 mL + 12 μg/0.5 mL + 10 μg/0.5 mL + 25 μg/0.5 mL + 29 DU/0.5 mL + 7 DU/0.5 mL + 26 DU/0.5 mL + 10 Lf (>= 40 IU)/0.5 mL | injection, suspension | Authorised | Sanofi-Aventis Singapore Pte. LTD. |
| Pentaxim VaccineCombination | Singapore | min. 20 IU (30 Lf)/0.5 mL + 25 μg/0.5 mL + 25 μg/0.5 mL + 29 DU/0.5 mL + 7 DU/0.5 mL + 26 DU/0.5 mL + min. 40 IU (10 Lf) /0.5 mL + 10 μg/0.5 mL + 18 - 30 μg/0.5 mL | injection, powder, for suspension | Authorised | Sanofi-Aventis Singapore Pte. LTD. |
| Infanrix Hexa VaccineCombination | Singapore | min 30 iu/0.5 ml + 25 mcg/0.5 ml + 10 mcg/0.5 ml + 10 mcg/0.5 ml + 8 mcg/0.5 ml + 25 mcg/0.5 ml + 40 du/0.5 ml + 8 du/0.5 ml + 32 du/0.5 ml + min 40 iu/0.5 ml | injection | Authorised | Glaxosmithkline Pte LTD |
| QuadracelCombination | United States | 0.5ML | Injection | Not marketed | Sanofi Vaccines Canada Ltd. |
| Infanrix Penta | European Union | Cancelled | GlaxoSmithKline Biologicals S.A. | ||
| PentaximCombination | Saudi Arabia | Authorised | Sanofi Pasteur | ||
| Infanrix Hexa VaccineCombination | Saudi Arabia | Authorised | Glaxosmithkline (GSK) | ||
| Hexavac | European Union | Withdrawn | Sanofi Pasteur MSD, SNC | ||
| Hexaxim VaccineCombination | Saudi Arabia | Authorised | Sanofi Pasteur SA |
Brand names
The same brand on several registers.
Often combined with
Substances it shares a medicine with.
Sources
Compiled by Prognia from the public medicine registers of SFDA. Each medicine’s page names its own source, licence and attribution.
Report an error or request removalCorrections from a register or a company are welcome.
For reference and learning, not treatment advice. Always check the official product information.
At a glance
- Registers
- 1
- Medicines
- 1
- Companies
- 1